We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$130M
AUM Growth
+$26.6M
(+26%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
26.04%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
800
New
284
Increased
141
Reduced
77
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sensata Technologies
ST
|
+$1.38M |
| 2 |
Mastercard
MA
|
+$1.33M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.33M |
| 4 |
Abbott
ABT
|
+$1.31M |
| 5 |
Universal Health Services
UHS
|
+$1.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17M |
| 2 |
Teradata
TDC
|
+$1.08M |
| 3 |
Phillips 66
PSX
|
+$1.05M |
| 4 |
Marathon Petroleum
MPC
|
+$1.05M |
| 5 |
Pentair
PNR
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.22% |
| 2 | Financials | 13.03% |
| 3 | Industrials | 12.41% |
| 4 | Technology | 11.95% |
| 5 | Healthcare | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Transocean
RIG
$5.48B
| $354K | 0.27% |
11,060
+6,295
| +132% | +$246K |
|
127
Aflac
AFL
$65.5B
| $350K | 0.27% |
+12,000
| New | +$365K |
|
|
AKS
128
DELISTED
AK Steel Holding Corp
AKS
| $348K | 0.27% |
+43,467
| New | +$405K |
|
129
Enovis
ENOV
$1.74B
| $348K | 0.27% |
+3,544
| New | +$398K |
|
130
Murphy Oil
MUR
$5.55B
| $347K | 0.27% |
6,100
+4,200
| +221% | +$260K |
|
131
Micron Technology
MU
$835B
| $347K | 0.27% |
+10,118
| New | +$328K |
|
132
Scotiabank
BNS
$105B
| $346K | 0.27% |
+5,975
| New | +$372K |
|
133
Rayonier Advanced Materials
RYAM
$562M
| $345K | 0.26% |
+10,492
| New | +$368K |
|
134
Norwegian Cruise Line
NCLH
$9.53B
| $345K | 0.26% |
+9,575
| New | +$325K |
|
135
Applied Materials
AMAT
$347B
| $343K | 0.26% |
+15,877
| New | +$351K |
|
136
Pacira BioSciences
PCRX
$1.04B
| $339K | 0.26% |
+3,501
| New | +$341K |
|
|
PDLI
137
DELISTED
PDL BioPharma, Inc.
PDLI
| $338K | 0.26% |
+45,300
| New | +$421K |
|
138
TripAdvisor
TRIP
$1.7B
| $338K | 0.26% |
+3,700
| New | +$366K |
|
139
Allegion
ALLE
$13.5B
| $337K | 0.26% |
7,066
+5,800
| +458% | +$304K |
|
|
BWLD
140
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $336K | 0.26% |
+2,500
| New | +$370K |
|
141
General Dynamics
GD
$103B
| $330K | 0.25% |
+2,600
| New | +$316K |
|
142
DigitalBridge
DBRG
$2.92B
| $330K | 0.25% |
+4,475
| New | +$337K |
|
|
TTM
143
DELISTED
Tata Motors Limited
TTM
| $326K | 0.25% |
+7,449
| New | +$326K |
|
144
Western Union
WU
$2.53B
| $319K | 0.25% |
+19,909
| New | +$343K |
|
145
Ubiquiti
UI
$31.6B
| $319K | 0.24% |
+8,500
| New | +$361K |
|
|
SIRO
146
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $319K | 0.24% |
+4,155
| New | +$334K |
|
|
APC
147
DELISTED
Anadarko Petroleum
APC
| $314K | 0.24% |
+3,100
| New | +$334K |
|
148
O-I Glass
OI
$1.18B
| $313K | 0.24% |
12,000
+10,800
| +900% | +$339K |
|
149
Omnicom Group
OMC
$22.7B
| $311K | 0.24% |
4,512
+2,300
| +104% | +$164K |
|
150
Century Aluminum
CENX
$4.22B
| $309K | 0.24% |
+11,900
| New | +$262K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Seven Eight Capital held 800 positions worth $130M, up 26% from $104M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $34M of net new capital in Q3 2014, opening 284 new positions and adding to 141 existing holdings. Its largest new stake was Sensata Technologies: 29,200 shares worth $1.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Teradata, an estimated $1.08M trimmed.
- Seven Eight Capital's largest Q3 2014 buy was Sensata Technologies: 29,200 shares worth $1.3M.
- Seven Eight Capital added most to Medtronic in Q3 2014, an estimated $1.27M increase.
- Seven Eight Capital's biggest Q3 2014 reduction was Teradata, cutting an estimated $1.08M.
- Seven Eight Capital fully exited Allergan plc in Q3 2014, selling an estimated $1.17M.
- Seven Eight Capital's ten largest holdings make up 10% of its $130M portfolio in Q3 2014.
- Seven Eight Capital opened 284 new positions and closed 294 in Q3 2014.
- Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $130M.
Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.